Vasundhara Rasayans Limited (BOM:538634)
118.15
-4.10 (-3.35%)
At close: Nov 17, 2026
Vasundhara Rasayans Revenue
Vasundhara Rasayans had revenue of 44.27M INR in the quarter ending September 30, 2026, a decrease of -49.81%. This brings the company's total for the last twelve months to 295.25M, down -10.42% year-over-year. In the fiscal year ending March 31, 2026, Vasundhara Rasayans had annual revenue of 357.23M with 5.10% growth. That makes Vasundhara Rasayans the 41,371st largest company in the world by revenue and 4,133rd in India.
Revenue (ttm)
295.25M
Revenue Growth
-10.42%
P/S Ratio
1.32
Revenue / Employee
7.03M
Employees
42
Market Cap
375.50M
Revenue by Geography
- India 219.86M 61.5%
- Export 137.37M 38.5%
Fiscal year ended Mar 31, 2026 See the full Vasundhara Rasayans breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 357.23M | 17.33M | 5.10% |
| Mar 31, 2025 | 339.90M | -30.28M | -8.18% |
| Mar 31, 2024 | 370.18M | -9.23M | -2.43% |
| Mar 31, 2023 | 379.41M | 111.91M | 41.83% |
| Mar 31, 2022 | 267.50M | 40.71M | 17.95% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Supha Pharmachem | 5.27B |
| Panchsheel Organics | 1.08B |
| Tyche Industries | 503.78M |
| Auro Laboratories | 407.90M |
| Crestchem | 338.33M |
| Link Pharma Chem | 274.60M |
| Krebs Biochemicals & Industries | 268.57M |
| Venmax Drugs and Pharmaceuticals | 132.58M |